Nuvation Bio (NYSE:NUVB) Given New $7.00 Price Target at HC Wainwright
Nuvation Bio (NYSE:NUVB – Free Report) had its price objective trimmed by HC Wainwright from $8.00 to $7.00 in a research report released on Monday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on NUVB. Royal Bank of Canada reissued an outperform rating and […]
More Stories
Trust Point Inc. Increases Stock Holdings in Discover Financial Services (NYSE:DFS)
Trust Point Inc. lifted its stake in shares of Discover Financial Services (NYSE:DFS) by 6.5% during the 1st quarter, HoldingsChannel.com...
Moody’s Corporation (NYSE:MCO) Shares Sold by Mission Wealth Management LP
Mission Wealth Management LP lessened its stake in Moody’s Corporation (NYSE:MCO – Free Report) by 9.0% in the 1st quarter,...
Brighton Jones LLC Acquires New Position in VeriSign, Inc. (NASDAQ:VRSN)
Brighton Jones LLC acquired a new stake in shares of VeriSign, Inc. (NASDAQ:VRSN – Free Report) during the first quarter,...
Freeport-McMoRan Inc. (NYSE:FCX) Shares Sold by Trust Point Inc.
Trust Point Inc. cut its position in shares of Freeport-McMoRan Inc. (NYSE:FCX – Free Report) by 17.5% in the 1st...
Mission Wealth Management LP Sells 353 Shares of Rio Tinto PLC (NYSE:RIO)
Mission Wealth Management LP lessened its stake in shares of Rio Tinto PLC (NYSE:RIO – Free Report) by 3.7% in...
Mission Wealth Management LP Increases Stock Holdings in Prologis, Inc. (NYSE:PLD)
Mission Wealth Management LP increased its holdings in shares of Prologis, Inc. (NYSE:PLD – Free Report) by 17.3% during the...